$AIMD
Ainos, Inc.

2019 Q3 Form 10-Q Financial Statement

#000101476319000013 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2018 Q4 2018 Q3
Revenue $4.786K $10.00K $14.91K
YoY Change -67.9%
Cost Of Revenue $3.368K $0.00 $16.79K
YoY Change -79.94%
Gross Profit $1.418K $0.00 -$1.883K
YoY Change -175.31%
Gross Profit Margin 29.63% 0.0% -12.63%
Selling, General & Admin $366.8K $450.0K $307.0K
YoY Change 19.5% 150.0% 32.96%
% of Gross Profit 25869.11%
Research & Development $30.00K
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $366.8K $490.0K $307.0K
YoY Change 19.5% 172.22% 32.96%
Operating Profit -$365.4K -$490.0K -$308.8K
YoY Change 18.31% 172.22% 33.77%
Interest Expense -$809.00 $0.00 $1.191K
YoY Change -167.93% -100.0% -38.26%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$370.0K -$490.0K -$310.0K
YoY Change 19.35% 133.33% 34.78%
Income Tax
% Of Pretax Income
Net Earnings -$366.2K -$500.0K -$310.0K
YoY Change 18.12% 138.1% 33.18%
Net Earnings / Revenue -7651.8% -5000.0% -2079.68%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.14 -$0.20 -$0.13
COMMON SHARES
Basic Shares Outstanding 40.22M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2018 Q4 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $480.0K $1.280M $1.140M
YoY Change -57.89% -35.35% 660.0%
Cash & Equivalents $482.8K $1.277M $1.143M
Short-Term Investments
Other Short-Term Assets $60.00K $30.00K $50.00K
YoY Change 20.0% -62.5% -28.57%
Inventory $6.363K
Prepaid Expenses
Receivables $4.196K $10.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $551.8K $1.303M $1.196M
YoY Change -53.87% -37.48% 463.37%
LONG-TERM ASSETS
Property, Plant & Equipment $1.753K $14.01K $19.00K
YoY Change -90.77% -48.11% -39.31%
Goodwill $133.4K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $139.9K $160.5K $320.9K
YoY Change -56.41% -23.36% 52.42%
TOTAL ASSETS
Total Short-Term Assets $551.8K $1.303M $1.196M
Total Long-Term Assets $139.9K $160.5K $320.9K
Total Assets $691.7K $1.464M $1.517M
YoY Change -54.41% -36.19% 258.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $180.0K $120.0K $140.0K
YoY Change 28.57% -25.0% -22.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $380.0K $510.0K $510.0K
YoY Change -25.49% -42.7% -42.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $612.6K $733.6K $707.3K
YoY Change -13.39% -59.76% -49.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $612.6K $733.6K $707.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $612.6K $733.6K $707.3K
YoY Change -13.39% -59.76% -49.53%
SHAREHOLDERS EQUITY
Retained Earnings -$4.400M -$3.188M -$2.702M
YoY Change 62.81% 69.23% 61.3%
Common Stock $402.2K $391.2K $373.0K
YoY Change 7.82% 68.93% 61.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $79.08K $730.1K $809.7K
YoY Change
Total Liabilities & Shareholders Equity $691.7K $1.464M $1.517M
YoY Change -54.41% -36.19% 258.78%

Cashflow Statement

Concept 2019 Q3 2018 Q4 2018 Q3
OPERATING ACTIVITIES
Net Income -$366.2K -$500.0K -$310.0K
YoY Change 18.12% 138.1% 33.18%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$240.0K -$310.0K -$310.0K
YoY Change -22.58% -11.43% 933.33%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $60.00K
YoY Change -100.0%
Cash From Investing Activities $0.00 -$70.00K $60.00K
YoY Change -100.0% 600.0% -700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 450.0K 0.000
YoY Change -79.55% -100.0%
NET CHANGE
Cash From Operating Activities -240.0K -310.0K -310.0K
Cash From Investing Activities 0.000 -70.00K 60.00K
Cash From Financing Activities 0.000 450.0K 0.000
Net Change In Cash -240.0K 70.00K -250.0K
YoY Change -4.0% -96.2% -412.5%
FREE CASH FLOW
Cash From Operating Activities -$240.0K -$310.0K -$310.0K
Capital Expenditures $0.00 $0.00 $10.00K
Free Cash Flow -$240.0K -$310.0K -$320.0K
YoY Change -25.0% -13.89% 700.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001014763
CY2019Q3 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
48177624
amar Dividends Payable Reversed
DividendsPayableReversed
amar Dividends Payable Reversed
DividendsPayableReversed
34277
CY2019Q3 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
376526
CY2018Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
513356
amar Proceeds From The Acquisition Of Aei
ProceedsFromTheAcquisitionOfAEI
amar Proceeds From The Acquisition Of Aei
ProceedsFromTheAcquisitionOfAEI
63414
amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
37500
amar Repayments Of Convertible Notes Payable Related Party Debt
RepaymentsOfConvertibleNotesPayableRelatedPartyDebt
195000
amar Reversal Of Dividends On Preferred Stock
ReversalOfDividendsOnPreferredStock
34277
amar Stock Issued During Period Value Debt
StockIssuedDuringPeriodValueDebt
100000
amar Stock Issued During Period Value Debt
StockIssuedDuringPeriodValueDebt
178125
amar Stock Issued During Period Value Subscription
StockIssuedDuringPeriodValueSubscription
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
93250
amar Stock Issued For Accrued Liabilities
StockIssuedForAccruedLiabilities
77250
dei Entity Registrant Name
EntityRegistrantName
AMARILLO BIOSCIENCES INC
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
25000
amar Stock Issued For Advances From Investors
StockIssuedForAdvancesFromInvestors
721033
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
179847
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
115313
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4196
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4076434
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3527238
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
288447
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
10277
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
28488
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
18269
CY2019Q3 us-gaap Assets
Assets
691682
CY2018Q4 us-gaap Assets
Assets
1463700
CY2019Q3 us-gaap Assets Current
AssetsCurrent
551807
CY2018Q4 us-gaap Assets Current
AssetsCurrent
1303234
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style=";font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="width:36pt;vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div></div></div> </td> <td style="vertical-align:top;"> <div style=" font-family:'Times New Roman', Times, serif;margin-right:0pt;margin-top:0pt;text-align:justify;margin-bottom:0pt;font-size:10pt;"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying consolidated financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 16, 2019, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2019 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019.</div></div> </td> </tr> </table></div>
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
482772
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1276654
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1980015
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1143317
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-793882
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-836698
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40216351
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39117524
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40216351
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39117524
CY2019Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
2078726
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
402164
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
391175
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
3368
CY2018Q3 us-gaap Cost Of Revenue
CostOfRevenue
16791
us-gaap Cost Of Revenue
CostOfRevenue
6649
us-gaap Cost Of Revenue
CostOfRevenue
60837
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
100000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
178125
CY2018Q4 us-gaap Liabilities
Liabilities
733621
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
691682
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1463700
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
612598
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
733621
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12500
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2043
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
55643
us-gaap Dividends
Dividends
0
CY2019Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
56225
CY2018Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
104952
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2019Q3 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
138122
CY2018Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
146456
CY2019Q3 us-gaap Gross Profit
GrossProfit
1418
CY2018Q3 us-gaap Gross Profit
GrossProfit
-1883
us-gaap Gross Profit
GrossProfit
2819
us-gaap Gross Profit
GrossProfit
10911
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2019Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-809
CY2018Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1191
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-172
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-3544
us-gaap Interest Paid Net
InterestPaidNet
727
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q3 us-gaap Inventory Net
InventoryNet
6363
CY2018Q4 us-gaap Inventory Net
InventoryNet
CY2019Q3 us-gaap Liabilities
Liabilities
612598
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-779339
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-697341
us-gaap Net Income Loss
NetIncomeLoss
-1211180
us-gaap Net Income Loss
NetIncomeLoss
-852589
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-366215
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-310039
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
366824
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
306965
us-gaap Operating Expenses
OperatingExpenses
1213827
us-gaap Operating Expenses
OperatingExpenses
859956
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-365406
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-308848
us-gaap Operating Income Loss
OperatingIncomeLoss
-1211008
us-gaap Operating Income Loss
OperatingIncomeLoss
-849045
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
26580
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
25000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1753
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14010
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
405
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2858
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1638
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4913
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58476
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52510
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4399514
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3188334
CY2019Q3 us-gaap Revenues
Revenues
4786
CY2018Q3 us-gaap Revenues
Revenues
14908
us-gaap Revenues
Revenues
9468
us-gaap Revenues
Revenues
71748
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
366824
CY2018Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
306965
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1161317
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
859956
CY2019Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.371
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
152301
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
73750
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
721034
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
69500
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
77250
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
730079
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
79084
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-470795
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
809739
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
79084
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
730079
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40156334
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35199804
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39684743
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34715330

Files In Submission

Name View Source Status
0001014763-19-000013-index-headers.html Edgar Link pending
0001014763-19-000013-index.html Edgar Link pending
0001014763-19-000013.txt Edgar Link pending
0001014763-19-000013-xbrl.zip Edgar Link pending
amar-20190930.xml Edgar Link completed
amar-20190930.xsd Edgar Link pending
amar-20190930_cal.xml Edgar Link unprocessable
amar-20190930_def.xml Edgar Link unprocessable
amar-20190930_lab.xml Edgar Link unprocessable
amar-20190930_pre.xml Edgar Link unprocessable
exhibit31-1_09302019.htm Edgar Link pending
exhibit32-1_09302019.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q_09302019.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending